Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1557 of 6351
-
New drug mimics IVIg to fight low platelet disorder
Disease control Recruiting nowThe purpose of the study is to evaluate the safety of NVG-2089 and to evaluate how well patients respond to this investigational treatment. NVG-2089 is a new drug that is being developed for treating patients with ITP. NVG-2089 is designed to mimic the effects of a protein called…
Phase 2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for CRPS sufferers: brain zaps and therapy combo put to the test
Symptom relief Recruiting nowThe aim of the study is to investigate and improve non-pharmacological rehabilitation methods for patients with Complex Regional Pain Syndrome (CRPS) to reduce pain and restore work and functional capacity to lower overall treatment costs. Current treatment methods offer limited …
Sponsor: Oulu University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Blood test may end misdiagnosis of bipolar disorder
Diagnosis Recruiting nowThe goal of this interventional clinical trial is to assess the diagnostic performance of a composite diagnostic medical devise based on blood-based in vitro diagnostic device and Mood Disorder Questionnaire (MDQ) in identifying bipolar disorder among adult patients presenting wi…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New pill may shrink lung tumors before surgery in Gene-Mutated cancers
Disease control Not yet recruitingThis is a prospective, single-center phase II clinical study aimed at evaluating the efficacy and safety of Vebreltinib in neoadjuvant treatment for patients with resectable stage IIA-IIIB (N2) non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations. In the study, …
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 13:55 UTC
-
Shockwaves in your heart: new device zaps artery calcium
Disease control Recruiting nowInterventional cardiologists are facing an increasing burden of calcified coronary arteries in keeping with an ageing population and rising prevalence of diabetes mellitus and chronic kidney disease. Heavily calcified plaques impede balloon dilatation and successful stent deliver…
Sponsor: National Heart Centre Singapore • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Rapid dual test for HIV and syphilis could save newborns in guatemala
Diagnosis CompletedThe purpose of this study is to determine if a strategy utilizing the Chembio HIV/syphilis rapid point-of-care (POC) test for diagnosis of HIV and syphilis in pregnant women attending prenatal clinics in Guatemala will increase screening and detection rates thereby resulting in h…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
Can unresponsive patients still form memories? new study investigates
Knowledge-focused Recruiting nowFollowing severe brain damage, some individuals lose partial or total awareness of themselves and their environment, falling into a coma that can evolve towards a Disorder of Consciousness (DoC). Accurately diagnosing the depth of consciousness alteration, and thus characterizing…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New study tests apremilast for psoriasis relief
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of Apremilast tablets in patients with psoriasis over 32 weeks, through a multicenter, single-arm, open-label, phase 4 clinical trial.
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for severe colitis: experimental drug BRS201 enters human trial
Disease control Recruiting nowThis study is a clinical trial being done to investigate the efficacy of drug BRS201 as a treatment in patients with acute ulcerative colitis. Patients who qualify are adults who have not responded to treatments for their severe ulcerative colitis. Participation in this study wil…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug YOLT-204 aims to reduce transfusions in blood disorders
Disease control Not yet recruitingThis is a single-arm, open-label, single-dose, dose-escalation trial that plans to enrol 3-18 patients with transfusion-dependent β-thalassaemia (TDT) or sickle-cell disease (SCD). Its primary aims are to evaluate the safety and tolerability of a single administration of YOLT-204…
Early phase 1 • Sponsor: Guangzhou Women and Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug crisugabalin takes on pregabalin in fibromyalgia pain showdown
Symptom relief Recruiting nowFibromyalgia (FM) is a chronic pain syndrome characterized by widespread pain, fatigue, and emotional disorders. Its onset is related to factors such as central sensitization and imbalance of neurotransmitters. The current mainstream treatments include pregabalin, but the efficac…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can your own blood help regrow hair? new trial tests PRP for scarring hair loss
Disease control Not yet recruitingThis study aims to investigate whether platelet-rich plasma (PRP) injections can help treat central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss that mostly affects women of African descent. CCCA is a condition that leads to permanent hair loss, usually s…
Phase 4 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for breast cancer patients who stopped responding to standard therapy
Disease control Recruiting nowThis is a prospective, single-arm, single-center, Phase II clinical study designed to assess the preliminary efficacy and safety of SKB264 Plus Inetetamab plus inetetamab for the treatment of HER2-positive, unresectable, locally advanced or metastatic breast cancer following prog…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New pill aims to melt liver fat in NASH patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if CS060380 tablets works to treat non-alcoholic steatohepatitis(NASH) in adults.It will also learn about the safety of CS060380 tablets.The main questions it aims to answer are: * After 12 weeks of administration, what was the percent…
Phase 2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New pill could help women stop leaking urine during exercise
Symptom relief Recruiting nowThe GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron works in adult female participants with stress urinary incontinence (SUI) who have obesity or overweight. SUI is leaking urine during m…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Virtual reality may mimic exercise benefits for sedentary people
Disease control Recruiting nowProlonged sedentary conditions contribute to declining health across human populations and cause significant secondary health consequences for many patients whose illnesses or injuries prevent them from exercising. The investigators have demonstrated that in a small animal fruit …
Sponsor: Wayne State University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New cocktail of cancer drugs targets Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis Phase I clinical trial evaluates the safety, tolerability, and optimal dosing of Zanzalintinib in combination with Pembrolizumab and Cetuximab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). The study aims to establish t…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for lymphoma patients: glofitamab studied in Real-World setting
Disease control Recruiting nowThis study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New rotating catheter aims to unclog leg arteries without major surgery
Disease control Recruiting nowThe XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.
Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Tailored cocktail of exercise, supplements, and drugs aims to slow aging
Disease control Recruiting nowAs the population ages, the growing prevalence of age-related diseases is creating substantial challenges for healthcare systems worldwide. Current therapeutic strategies often target individual diseases and decrease mortality without improving healthspan. The geroscience hypothe…
Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC